Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
J Biol Chem ; 292(11): 4743-4752, 2017 03 17.
Article in English | MEDLINE | ID: mdl-28174303

ABSTRACT

The precise signaling mechanisms by which type II IFN receptors control expression of unique genes to induce biological responses remain to be established. We provide evidence that Sin1, a known element of the mammalian target of rapamycin complex 2 (mTORC2), is required for IFNγ-induced phosphorylation and activation of AKT and that such activation mediates downstream regulation of mTORC1 and its effectors. These events play important roles in the assembly of the eukaryotic translation initiation factor 4F (eIF4F) and mRNA translation of IFN-stimulated genes. Interestingly, IFNγ-induced tyrosine phosphorylation of STAT1 is reduced in cells with targeted disruption of Sin1, leading to decreased transcription of several IFNγ-inducible genes in an mTORC2-independent manner. Additionally, our studies establish that Sin1 is essential for generation of type II IFN-dependent antiviral effects and antiproliferative responses in normal and malignant hematopoiesis. Together, our findings establish an important role for Sin1 in both transcription and translation of IFN-stimulated genes and type II IFN-mediated biological responses, involving both mTORC2-dependent and -independent functions.


Subject(s)
Adaptor Proteins, Signal Transducing/immunology , Carrier Proteins/immunology , Interferon-gamma/immunology , Animals , Cell Line , Humans , Immunity, Innate , Mice , Phosphorylation , Proto-Oncogene Proteins c-akt/chemistry , Proto-Oncogene Proteins c-akt/immunology , STAT1 Transcription Factor/chemistry , STAT1 Transcription Factor/immunology , Signal Transduction
2.
J Biol Chem ; 291(5): 2389-96, 2016 Jan 29.
Article in English | MEDLINE | ID: mdl-26645692

ABSTRACT

We provide evidence for a unique pathway engaged by the type II IFN receptor, involving mTORC2/AKT-mediated downstream regulation of mTORC1 and effectors. These events are required for formation of the eukaryotic translation initiation factor 4F complex (eIF4F) and initiation of mRNA translation of type II interferon-stimulated genes. Our studies establish that Rictor is essential for the generation of type II IFN-dependent antiviral and antiproliferative responses and that it controls the generation of type II IFN-suppressive effects on normal and malignant hematopoiesis. Together, our findings establish a central role for mTORC2 in IFNγ signaling and type II IFN responses.


Subject(s)
Carrier Proteins/metabolism , Eukaryotic Initiation Factor-4F/metabolism , Interferon-gamma/metabolism , Multiprotein Complexes/metabolism , Receptors, Interferon/metabolism , Signal Transduction , TOR Serine-Threonine Kinases/metabolism , Animals , Antiviral Agents/chemistry , Antiviral Agents/metabolism , Chemokine CXCL10/metabolism , Fibroblasts/metabolism , Gene Expression Regulation , Hematopoiesis , Hematopoietic Stem Cells/cytology , Humans , Interferon-Stimulated Gene Factor 3, gamma Subunit/metabolism , Mechanistic Target of Rapamycin Complex 1 , Mechanistic Target of Rapamycin Complex 2 , Mice , Mice, Knockout , Phosphorylation , Polyribosomes/metabolism , Protein Biosynthesis , Rapamycin-Insensitive Companion of mTOR Protein , U937 Cells
SELECTION OF CITATIONS
SEARCH DETAIL
...